• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆研究联盟:来自ISTAART路易体痴呆专业兴趣领域工作组的全球视角。

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group.

作者信息

D'Antonio Fabrizia, Kane Joseph P M, Ibañez Agustin, Lewis Simon J G, Camicioli Richard, Wang Huali, Yu Yueyi, Zhang Jing, Ji Yong, Borda Miguel Germán, Kandadai Rukmini Mridula, Babiloni Claudio, Bonanni Laura, Ikeda Manabu, Boeve Bradley F, Leverenz James B, Aarsland Dag

机构信息

Department of Human Neurosciences Sapienza University of Rome Rome Italy.

Centre for Public Health Queen's University Belfast Belfast UK.

出版信息

Alzheimers Dement (Amst). 2021 Sep 14;13(1):e12235. doi: 10.1002/dad2.12235. eCollection 2021.

DOI:10.1002/dad2.12235
PMID:34541289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8438683/
Abstract

Dementia with Lewy bodies (DLB) research has seen a significant growth in international collaboration over the last three decades. However, researchers face a challenge in identifying large and diverse samples capable of powering longitudinal studies and clinical trials. The DLB research community has begun to focus efforts on supporting the development and harmonization of consortia, while also continuing to forge networks within which data and findings can be shared. This article describes the current state of DLB research collaborations on each continent. We discuss several established DLB cohorts, many of whom have adopted a common framework, and identify emerging collaborative initiatives that hold the potential to expand DLB networks and diversify research cohorts. Our findings identify geographical areas into which the global DLB networks should seek to expand, and we propose strategies, such as the creation of data-sharing platforms and the harmonization of protocols, which may further potentiate international collaboration.

摘要

在过去三十年中,路易体痴呆(DLB)研究领域的国际合作显著增加。然而,研究人员在识别能够支持纵向研究和临床试验的大规模多样化样本方面面临挑战。DLB研究界已开始将精力集中在支持联盟的发展与协调上,同时也在继续构建能够共享数据和研究结果的网络。本文描述了各大洲DLB研究合作的现状。我们讨论了几个已建立的DLB队列,其中许多采用了共同框架,并确定了具有扩大DLB网络和使研究队列多样化潜力的新兴合作倡议。我们的研究结果确定了全球DLB网络应寻求扩展到的地理区域,并提出了一些策略,如创建数据共享平台和统一方案,这可能会进一步加强国际合作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/8438683/0718a9a4371d/DAD2-13-e12235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/8438683/5610b1a18ef8/DAD2-13-e12235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/8438683/0718a9a4371d/DAD2-13-e12235-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/8438683/5610b1a18ef8/DAD2-13-e12235-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe1/8438683/0718a9a4371d/DAD2-13-e12235-g001.jpg

相似文献

1
Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group.路易体痴呆研究联盟:来自ISTAART路易体痴呆专业兴趣领域工作组的全球视角。
Alzheimers Dement (Amst). 2021 Sep 14;13(1):e12235. doi: 10.1002/dad2.12235. eCollection 2021.
2
Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.路易体痴呆国际第二次研讨会报告:诊断与治疗。路易体痴呆联合会。
Neurology. 1999 Sep 22;53(5):902-5. doi: 10.1212/wnl.53.5.902.
3
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
4
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
5
Advances in dementia with Lewy bodies.路易体痴呆的进展
Ther Adv Neurol Disord. 2021 Nov 23;14:17562864211057666. doi: 10.1177/17562864211057666. eCollection 2021.
6
Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia.路易体痴呆:路易体痴呆症和帕金森病痴呆症。
Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):435-63. doi: 10.1212/CON.0000000000000309.
7
An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias.基于 iTRAQ 的蛋白质组学分析揭示路易体痴呆症患者新皮层突触蛋白聚糖失调。
Mol Brain. 2017 Aug 11;10(1):36. doi: 10.1186/s13041-017-0316-9.
8
Emerging drugs for dementia with Lewy Bodies: a review of Phase II & III trials.用于路易体痴呆的新型药物:II期和III期试验综述
Expert Opin Emerg Drugs. 2023 Dec;28(3):167-180. doi: 10.1080/14728214.2023.2244425. Epub 2023 Aug 8.
9
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.路易体痴呆与帕金森病痴呆:当前的概念和争议。
J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8.
10
Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.路易体痴呆与帕金森病痴呆的新临床病理特征有别。
Neuropathol Appl Neurobiol. 2021 Feb;47(1):143-156. doi: 10.1111/nan.12648. Epub 2020 Aug 12.

引用本文的文献

1
Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.路易体痴呆显性和前驱期生物学框架的意义与机遇
Alzheimers Dement. 2025 Jul;21(7):e70470. doi: 10.1002/alz.70470.
2
A common outcome set for trials in dementia with Lewy bodies (DLB COS).路易体痴呆试验的通用结局集(DLB COS)。
Alzheimers Dement (N Y). 2025 Jul 11;11(3):e70134. doi: 10.1002/trc2.70134. eCollection 2025 Jul-Sep.
3
Research on the perspectives of people affected by dementia with Lewy bodies: a scoping review.

本文引用的文献

1
Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.路易体轻度认知障碍患者心脏自主神经闪烁显像的准确性。
Neurology. 2021 Jun 8;96(23):e2801-e2811. doi: 10.1212/WNL.0000000000012060. Epub 2021 Apr 21.
2
Clinical characteristics of Lewy body dementia in Chinese memory clinics.中国记忆门诊路易体痴呆的临床特征。
BMC Neurol. 2021 Mar 31;21(1):144. doi: 10.1186/s12883-021-02169-w.
3
Dementia in Latin America: Paving the way toward a regional action plan.拉丁美洲的痴呆症:为区域行动计划铺平道路。
路易体痴呆症患者视角的研究:一项范围综述
Alzheimers Res Ther. 2025 May 26;17(1):117. doi: 10.1186/s13195-025-01760-4.
4
Lewy Body Dementia Research in Latin America: A Scoping Review.拉丁美洲的路易体痴呆症研究:一项范围综述。
Mov Disord Clin Pract. 2025 Apr 21. doi: 10.1002/mdc3.70059.
5
The 100 most influential papers on Lewy body dementias: a bibliometric analysis.关于路易体痴呆症的100篇最具影响力的论文:文献计量分析
Ann Med Surg (Lond). 2025 Jan 31;87(2):684-695. doi: 10.1097/MS9.0000000000002909. eCollection 2025 Feb.
6
Neuropsychological test performance in mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis.路易体轻度认知障碍的神经心理学测试表现:一项系统评价和荟萃分析。
Alzheimers Dement. 2025 Feb;21(2):e14450. doi: 10.1002/alz.14450. Epub 2025 Jan 10.
7
What is the future for dementia with Lewy bodies?路易体痴呆的未来会怎样?
J Neurol. 2024 Dec 12;272(1):43. doi: 10.1007/s00415-024-12734-1.
8
Optimal DaTQUANT Thresholds for Diagnostic Accuracy of Dementia with Lewy Bodies (DLB) and Parkinson's Disease (PD).最佳 DaTQUANT 阈值可提高路易体痴呆(DLB)和帕金森病(PD)的诊断准确性。
Tomography. 2024 Oct 9;10(10):1608-1621. doi: 10.3390/tomography10100119.
9
Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: An up to 10-year follow-up study.胆碱酯酶抑制剂和美金刚对路易体痴呆认知下降、心血管事件和死亡率的长期影响:一项长达 10 年的随访研究。
Alzheimers Dement. 2024 Oct;20(10):6740-6754. doi: 10.1002/alz.14118. Epub 2024 Aug 23.
10
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians.区分前驱期路易体痴呆与前驱期阿尔茨海默病:给临床医生的实用综述
Neurol Ther. 2024 Jun;13(3):885-906. doi: 10.1007/s40120-024-00620-x. Epub 2024 May 8.
Alzheimers Dement. 2021 Feb;17(2):295-313. doi: 10.1002/alz.12202. Epub 2020 Nov 20.
4
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.基因组测序分析鉴定出与路易体痴呆相关的新基因座,并深入了解其遗传结构。
Nat Genet. 2021 Mar;53(3):294-303. doi: 10.1038/s41588-021-00785-3. Epub 2021 Feb 15.
5
Sex differences for phenotype in pathologically defined dementia with Lewy bodies.路易体痴呆的病理定义中表型的性别差异。
J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):745-750. doi: 10.1136/jnnp-2020-325668. Epub 2021 Feb 9.
6
Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms.神经退行性疾病中的精神病:幻觉和妄想症状的不同模式。
Brain. 2021 Apr 12;144(3):999-1012. doi: 10.1093/brain/awaa413.
7
The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science.拉丁美洲和加勒比地区痴呆症联盟(LAC-CD):从网络建设到研究再到实施科学。
J Alzheimers Dis. 2021;82(s1):S379-S394. doi: 10.3233/JAD-201384.
8
β-Amyloid PET and I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia.β淀粉样蛋白PET和I-FP-CIT SPECT在路易体痴呆风险的轻度认知障碍中的应用
Neurology. 2021 Feb 22;96(8):e1180-e1189. doi: 10.1212/WNL.0000000000011454.
9
Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study.用于评估尸检大脑中 Lewy 病理的神经病理学共识标准:一项多中心研究。
Acta Neuropathol. 2021 Feb;141(2):159-172. doi: 10.1007/s00401-020-02255-2. Epub 2021 Jan 5.
10
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.改善路易体痴呆症临床试验格局的挑战与机遇。
Alzheimers Res Ther. 2020 Oct 29;12(1):137. doi: 10.1186/s13195-020-00703-5.